FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileHTG Molecular Diagnostics, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HTGMQ
HTG Molecular Diagnostics, Inc. Stock AnalysisComprehensive stock analysis for HTG Molecular Diagnostics, Inc. (HTGMQ) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHTGMQ
HTGMQ
HTG Molecular Diagnostics, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HTGMQ
  1. Home
  2. Stocks
  3. HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

🇺🇸HTGMQ•OTC

HTG Molecular Diagnostics, Inc.

🇺🇸HTGMQ•OTC
Market cap
$221
Sentiment

Your view on HTGMQ

Mkt Cap
$221
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About HTG Molecular Diagnostics, Inc.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
John L. Lubniewski
Headquarters
3430 East Global Loop, Tucson, AZ, US
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
John L. Lubniewski
Headquarters
3430 East Global Loop, Tucson, AZ, US
Description

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets.

Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel.

The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories.

The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for HTG Molecular Diagnostics, Inc. from FRC's valuation model, read against the market price. HTGMQ last traded at $0.0001; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for HTG Molecular Diagnostics, Inc.. Starting points for HTG Molecular Diagnostics, Inc.: EPS -$24.28, beta 2.76 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for HTG Molecular Diagnostics, Inc.. HTG Molecular Diagnostics, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for HTG Molecular Diagnostics, Inc.. Trailing twelve-month EPS for HTG Molecular Diagnostics, Inc. stands at -$24.28. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Analyst Ratings

Buy1 rating
  • Strong Buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrJun 2024Next QtrSep 2024Current YearFY Dec 2023Next YearFY Dec 2024
Avg. estimate-$2.16-$2.16-$4.63-$1.06
Low estimate-$2.16-$2.16-$4.63-$1.06
High estimate-$2.16-$2.16-$4.63-$1.06
No. of analysts1111
Year-ago EPS——-$24.28—
Growth——+80.9%—

Revenue Estimate

RevenueCurrent QtrJun 2024Next QtrSep 2024Current YearFY Dec 2023Next YearFY Dec 2024
Avg. estimate$5.30M$5.80M$6.40M$15.00M
Low estimate$5.30M$5.80M$6.40M$15.00M
High estimate$5.30M$5.80M$6.40M$15.00M
No. of analysts1111
Year-ago revenue——$6.37M—
Growth——+0.5%—
Recent analyst actions1 rating and price-target change, latest Apr 2, 2023 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for HTG Molecular Diagnostics, Inc.. HTG Molecular Diagnostics, Inc. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold HTGMQ20 companies
Compare HTGMQ with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • BIOCQBiocept, Inc.Medical - Diagnostics & Research$263
  • BRSFBrain Scientific Inc.Medical - Devices$124
  • BSPMBiostar Pharmaceuticals, Inc.Drug Manufacturers - Specialty & Generic$264
  • CLVRClever Leaves Holdings Inc.Drug Manufacturers - Specialty & Generic$702
  • CRFTFBC Craft Supply Co. Ltd.Drug Manufacturers - Specialty & Generic$23
  • HLTHQCue Health Inc.Medical - Specialties$159
  • MDVLQMedAvail Holdings, Inc.Medical - Pharmaceuticals$161
  • NEXINexImmune, Inc.Medical - Pharmaceuticals$279

More Medical - Diagnostics & Research companies

  • SHL.AXSonic Healthcare LimitedASX
  • SKHCFSonic Healthcare LimitedOTC$7.9B
  • AAgilent Technologies, Inc.NYSE$48.8B
  • ABDXFAbingdon Health PlcOTC$13M
  • ACL.AXAustralian Clinical Labs LimitedASX
  • ADVBAdvanced Biomed Inc. Common StockNASDAQ$4M
  • ANPCFCellbxhealth PLCOTC$4M
  • ARYCArrayit CorporationOTC$79,348
  • AVCR.VAvricore Health Inc.TSXV$3M
  • AVCRFAvricore Health Inc.OTC$6M
  • BDSXBiodesix, Inc.NASDAQ$73M
  • BDX.AXBCAL Diagnostics LimitedASX
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for HTG Molecular Diagnostics, Inc.. Coverage tracks HTG Molecular Diagnostics, Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of HTG Molecular Diagnostics, Inc.

HTGMQ Analysis
Weak
Past2
Growth1
Health3
Profit1
Value1

News

Latest Market News